Abstract:Background: Syndrome (ZHENG in Chinese) in traditional Chinese medicine (TCM) refers to the intrinsic characteristics of a pathological process at a certain stage; these characteristics are influenced by internal and external environments and reveal the nature of a disease. Proper syndrome differentiation is the basic principle that guides clinical treatment. Objective: To have a good understanding of tumor progression and the different mechanisms related to ZHENG that have occurred before and after tumor development and to explore the valid evaluation criteria of different pancreatic cancer syndromes to improve the guiding role of TCM syndrome differentiation in pancreatic cancer treatment. Methods: In this study, we established mouse subcutaneous pancreatic cancer models, namely, Con (control), Pi-Xu (Spleen-Deficiency), Shi-Re (Dampness-Heat), and Xue-Yu (Blood-Stasis). Then, for the first time, we compared the different effects of ZHENG-first (referring to a different disease status that occurred before tumor occurrence) and Tumor-first (referring to the change in the tumor microenvironment and the resulting changes in the state of the body) conditions on tumor progression and evaluated the associated molecular mechanisms. Results: We found that tumor growth in the ZHENG-first and Tumor-first conditions was different. In the Tumor-first model, the tumor growth in the Pi-Xu group was faster than that in the other groups. However, in the ZHENG-first model, the tumor growth trend was most obvious in the Shi-Re group. There was a difference in tumor-associated macrophage infiltration between the 2 models. The expression levels of the inflammatory cytokines IL-6, IL-10, and P-STAT3 were also differentially altered. Conclusion: The emergence of ZHENG conditions before or after tumor occurrence had different impacts on pancreatic cancer development, and these impacts may be related to differences in tumor-associated macrophage infiltration and the involved inflammatory cytokines IL-6, IL-10, and P-STAT3. The study results uncovered the molecular basis of syndrome differentiation in pancreatic cancer progression, which might provide more specific guidance for TCM treatment of pancreatic cancer.

Pancreatic Malformations As Seen in Congenital Syndromes — Developmental Perspective with an Alternative View

Congenital syndromes involving the lungs: pathogenetic models based on chinese medicine theories

The Emerging Genetic Basis and Its Clinical Implication in Pancreatic Cancer

Human Phenome based on traditional Chinese medicine--a solution to congenital syndromology

Analyzing the TCM Syndromes of Pancreatic Cancer

The Molecular Mechanisms of Traditional Chinese Medicine Zheng Syndromes on Pancreatic Tumor Growth

Mesenteric Heterotopic Pancreas in a Pediatric Patient: A Case Report and Review of Literature

The Clinical Utility of CA125/MUC16 in Pancreatic Cancer: A Consensus of Diagnostic, Prognostic and Predictive Updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)

Advances and Comments on Traditional Chinese Medicine Syndrome and Treatment on Pancreatic Cancer

Tam Infiltration Differences In "Tumor-First" And "Zheng-First" Models And The Underlying Inflammatory Molecular Mechanism In Pancreatic Cancer

Congenital Anomalies of the Pancreas: Various Clinical Manifestations and Their Impact on Pancreatic Diseases and Outcomes

From "different Patterns in the Same Disease" to "analogous Patterns in the Same Disease"

Genotypes and phenotypes of capillary malformation–arteriovenous malformation: characterization and correlation analysis

Clinical Characteristics and Endoscopic Treatment of Pancreatitis Caused by Pancreaticobiliary Malformation in Chinese Children.

Annular Pancreas Concurrent with Pancreaticobiliary Maljunction Presented with Symptoms until Adult Age: Case Report with Comparative Data on Pediatric Cases

Anatomical and Morphological Features of the Fetal Human Pancreaticobiliary Ductal Union.

Development of a CT-based radiomics-clinical model to diagnose acute pancreatitis on nonobvious findings on CT in children with pancreaticobiliary maljunction

Variant anatomy of the biliary system as a cause of pancreatic and peri-ampullary cancers

Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes

Pancreatic congenital anomalies and their features on CT and MR imaging: a pictorial review

Classification of Pancreaticobiliary Maljunction and Clinical Features in Children.